HIGHLIGHTS
- who: Marialaura Amadio from the Department of Drug Sciences, Section of Pharmacology, University of Pavia, Pavia, Italy have published the research: Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat, in the Journal: (JOURNAL)
- what: The authors aimed to evaluate whether specifically and directly targeting HuR may represent a new therapeutic strategy to hinder VEGF overexpression. The authors loaded solid lipid nanoparticles (SLN) and liposomes loaded with siRNA silencing HuR expression, to assess their pharmacological profiles in a DR model. The major goal of clinical therapeutics is to provide and maintain effective . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.